-+ 0.00%
-+ 0.00%
-+ 0.00%

PDS BIOTECH ANNOUNCES PUBLICATION OF VERSATILE-002 PHASE 2 CLINICAL TRIAL RESULTS OF PDS0101 WITH PEMBROLIZUMAB IN HPV16-POSITIVE RECURRENT AND/OR METASTATIC (R/M) HEAD AND NECK CANCER IN JAMA ONCOLOGY

Reuters·09/22/2026 12:00:02

Please log in to view news